MT-5050

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMT-5050
Drug Alias NamePD-L1 targeting ETB (Molecular Templates)PD-L1-targeted immunotoxin (Molecular Templates)MT-5050
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionProgrammed death-ligand 1 modulators
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMolecular Templates Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecular Templates Inc
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A